Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives

The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care. A survey questionnaire was developed to explore the experiences and opinions about EOL...

Full description

Saved in:
Bibliographic Details
Published inCancer research and treatment Vol. 50; no. 2; pp. 614 - 623
Main Authors Koh, Su-Jin, Kim, Shinmi, Kim, JinShil, Keam, Bhumsuk, Heo, Dae Seog, Lee, Kyung Hee, Kim, Bong-Seog, Kim, Jee Hyun, Chang, Hye Jung, Baek, Sun Kyung
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Cancer Association 01.04.2018
대한암학회
Subjects
Online AccessGet full text
ISSN1598-2998
2005-9256
2005-9256
DOI10.4143/crt.2016.446

Cover

Abstract The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care. A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses. A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion. This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required.
AbstractList The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care.PURPOSEThe aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care.A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses.MATERIALS AND METHODSA survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses.A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion.RESULTSA total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion.This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required.CONCLUSIONThis study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required.
Purpose The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care. Materials and Methods A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses. Results A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of “terminal state,” and most respondents tried to disclose the patient’s condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussion was considered when metastasis or disease recurrence occurred or when withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion. Conclusion This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required. KCI Citation Count: 0
The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL discussions as a means to improve the quality of EOL care. A survey questionnaire was developed to explore the experiences and opinions about EOL discussions among oncologists and residents. Descriptive statistics, the t test, and the chisquare test were performed for the analyses. A total of 147 oncologists and 229 residents participated in this study. The study respondents reported diverse definitions of "terminal state," and mostrespondents tried to disclose the patient's condition to the patient and/or family members. Both groups were involved in EOL care discussions, with a rather low satisfaction level (57.82/100). The best timing to initiate discussionwas consideredwhen metastasis or disease recurrence occurred orwhen withdrawal of chemotherapy was anticipated. Furthermore, the study respondents suggested that patients and their family members should be included in the EOL discussion. Medical, legal, and ethical knowledge and communication difficulties along with practical issues were revealed as barriers and facilitators for EOL discussion. This study explored various perspectives of oncologists and resident physicians for EOL discussion. Since the Life-Sustaining-Treatment Decision-Making Act will be implemented shortly in Korea, now is the time for oncologists and residents to prepare themselves by acquiring legal knowledge and communication skills. To achieve this, education, training, and clinical tools for healthcare professionals are required.
Author Chang, Hye Jung
Kim, Shinmi
Kim, JinShil
Koh, Su-Jin
Baek, Sun Kyung
Keam, Bhumsuk
Lee, Kyung Hee
Kim, Jee Hyun
Heo, Dae Seog
Kim, Bong-Seog
Author_xml – sequence: 1
  givenname: Su-Jin
  surname: Koh
  fullname: Koh, Su-Jin
– sequence: 2
  givenname: Shinmi
  surname: Kim
  fullname: Kim, Shinmi
– sequence: 3
  givenname: JinShil
  surname: Kim
  fullname: Kim, JinShil
– sequence: 4
  givenname: Bhumsuk
  surname: Keam
  fullname: Keam, Bhumsuk
– sequence: 5
  givenname: Dae Seog
  surname: Heo
  fullname: Heo, Dae Seog
– sequence: 6
  givenname: Kyung Hee
  surname: Lee
  fullname: Lee, Kyung Hee
– sequence: 7
  givenname: Bong-Seog
  surname: Kim
  fullname: Kim, Bong-Seog
– sequence: 8
  givenname: Jee Hyun
  surname: Kim
  fullname: Kim, Jee Hyun
– sequence: 9
  givenname: Hye Jung
  surname: Chang
  fullname: Chang, Hye Jung
– sequence: 10
  givenname: Sun Kyung
  surname: Baek
  fullname: Baek, Sun Kyung
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28675025$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002335623$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kc1v1DAQxS1URLeFG2eUGyCRxXYcx-GAVJUtVFppq1U5W8aZtKZZO3icwv73eLvlU4LTHOY38-a9OSIHPngg5Cmjc8FE9drGNOeUybkQ8gGZcUrrsuW1PCAzVreq5G2rDskR4mdKpaga9ogcciWbmvJ6RnDxbYTowFvAwviuWI3Ou-CxWMNgEnRFCsXCd2Xoy6XroXjn0E6IGXlTnMWwKVbehiFcOUz4_G7DGtB14FNxcb1FZ53xuXEBEUewyd0CPiYPezMgPLmvx-Tj2eLy9EO5XL0_Pz1ZllYokcp8ay1tpZqGGgGtgL7hnZS9BcFUNsXAis5mqgEOnEnBqWwsFx0DaVvg1TF5ud_rY69vrNPBuLt6FfRN1Cfry3NdsZpRqTJb7tnJj2b71QyDHqPbmLjVjOpd0DoHrXdB6xx05t_u-XH6tIHOZr_R_JrZKf3Z8e46697qumWcid1xL-4XxPBlAkx6k5OFYTAewoSataxWiucIMvrsd62fIj--mAG-B2wMiBF6bV0yKf8oS7vhXw5e_TX0X8PfAf3Zv6E
CitedBy_id crossref_primary_10_1016_j_ijnss_2024_03_010
crossref_primary_10_1186_s12904_021_00759_6
crossref_primary_10_4143_crt_2020_735
crossref_primary_10_21215_kjfp_2021_11_5_331
crossref_primary_10_4143_crt_2019_740
crossref_primary_10_1089_pmr_2022_0008
crossref_primary_10_1089_jpm_2019_0402
crossref_primary_10_1186_s12910_024_01088_y
crossref_primary_10_1016_j_ijnurstu_2019_03_020
crossref_primary_10_1186_s12904_020_00652_8
crossref_primary_10_1177_26323524231212510
crossref_primary_10_1186_s12910_023_00897_x
crossref_primary_10_1007_s00520_020_05750_0
crossref_primary_10_1093_qjmed_hcad246
crossref_primary_10_1016_j_jamda_2020_12_018
crossref_primary_10_1016_j_pec_2018_08_016
crossref_primary_10_1093_jjco_hyaa131
crossref_primary_10_1177_10499091211061713
crossref_primary_10_1016_j_jpainsymman_2018_12_332
crossref_primary_10_1177_0825859718777361
crossref_primary_10_3947_ic_2019_51_2_89
Cites_doi 10.3399/bjgp10X544032
10.4082/kjfm.2014.35.6.283
10.1146/annurev.clinpsy.1.102803.144118
10.3399/bjgp13X673667
10.1080/15265161003599691
10.1016/S0749-3797(99)00097-5
10.1007/s00520-012-1689-z
10.1111/jgs.12894
10.1200/JCO.2016.70.1474
10.1097/PPO.0b013e3182a76b9c
10.1017/S1478951515000590
10.4143/crt.2015.124
10.1097/NJH.0000000000000034
10.1177/0272989X13501883
ContentType Journal Article
Copyright Copyright © 2018 by the Korean Cancer Association 2018
Copyright_xml – notice: Copyright © 2018 by the Korean Cancer Association 2018
DBID AAYXX
CITATION
NPM
7X8
5PM
ADTOC
UNPAY
ACYCR
DOI 10.4143/crt.2016.446
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-9256
EndPage 623
ExternalDocumentID oai_kci_go_kr_ARTI_3151068
10.4143/crt.2016.446
PMC5912142
28675025
10_4143_crt_2016_446
Genre Journal Article
GroupedDBID ---
29B
5-W
53G
8JR
9ZL
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
HYE
OK1
RPM
TR2
C1A
M~E
NPM
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c484t-43756c38770a4e94ef72d66fce4189981ec4dc4377e2e21642067c24d1e6c9e23
IEDL.DBID UNPAY
ISSN 1598-2998
2005-9256
IngestDate Sun Mar 09 07:55:05 EDT 2025
Wed Oct 29 12:03:00 EDT 2025
Thu Aug 21 17:31:00 EDT 2025
Thu Oct 02 10:35:38 EDT 2025
Wed Feb 19 02:43:19 EST 2025
Thu Apr 24 23:06:40 EDT 2025
Tue Jul 01 03:18:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Oncologists
Advance care planning
Resident physician
Communication
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
cc-by-nc
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c484t-43756c38770a4e94ef72d66fce4189981ec4dc4377e2e21642067c24d1e6c9e23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=http://www.e-crt.org/upload/pdf/crt-2016-446.pdf
PMID 28675025
PQID 1915882756
PQPubID 23479
PageCount 10
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_3151068
unpaywall_primary_10_4143_crt_2016_446
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5912142
proquest_miscellaneous_1915882756
pubmed_primary_28675025
crossref_citationtrail_10_4143_crt_2016_446
crossref_primary_10_4143_crt_2016_446
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Cancer research and treatment
PublicationTitleAlternate Cancer Res Treat
PublicationYear 2018
Publisher Korean Cancer Association
대한암학회
Publisher_xml – name: Korean Cancer Association
– name: 대한암학회
References ref13
ref12
ref15
ref14
ref11
(ref1) 2008
ref2
Berlinger (ref18) 2013
ref17
ref16
Rogne (ref3) 2014
(ref4) 2014
Ryan (ref23) 2014
Ngo-Metzger (ref19) 2008
ref22
ref21
(ref10) 2016
Institute of (ref25) 2015
Meisel (ref24) 2008
(ref20) 2016
(ref8) 2015
ref7
ref9
ref6
ref5
References_xml – ident: ref22
  doi: 10.3399/bjgp10X544032
– start-page: 45
  year: 2014
  ident: ref23
– ident: ref21
  doi: 10.4082/kjfm.2014.35.6.283
– volume-title: Korea Law Information Center [Internet]
  year: 2016
  ident: ref10
– ident: ref2
  doi: 10.1146/annurev.clinpsy.1.102803.144118
– ident: ref11
  doi: 10.3399/bjgp13X673667
– ident: ref5
  doi: 10.1080/15265161003599691
– year: 2016
  ident: ref20
– year: 2014
  ident: ref4
– ident: ref14
  doi: 10.1016/S0749-3797(99)00097-5
– ident: ref13
  doi: 10.1007/s00520-012-1689-z
– year: 2015
  ident: ref25
– start-page: 1
  year: 2014
  ident: ref3
– ident: ref6
  doi: 10.1111/jgs.12894
– ident: ref16
  doi: 10.1200/JCO.2016.70.1474
– start-page: 51
  year: 2008
  ident: ref24
– volume-title: Chapter 9. Coverage of hospice services under hospital insurance (Rev.209.) [Internet]
  year: 2015
  ident: ref8
– year: 2013
  ident: ref18
– ident: ref15
  doi: 10.1097/PPO.0b013e3182a76b9c
– start-page: 167
  volume-title: End-of-Life care: guidelines for patient-centered communication
  year: 2008
  ident: ref19
– year: 2008
  ident: ref1
– ident: ref9
  doi: 10.1017/S1478951515000590
– ident: ref12
  doi: 10.4143/crt.2015.124
– ident: ref17
  doi: 10.1097/NJH.0000000000000034
– ident: ref7
  doi: 10.1177/0272989X13501883
SSID ssj0064371
Score 2.2470746
Snippet The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on EOL...
Purpose The aims of this study were to explore how oncologists and resident physicians practice end-of-life (EOL) discussions and to solicit their opinions on...
SourceID nrf
unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 614
SubjectTerms Original
의약학
Title Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives
URI https://www.ncbi.nlm.nih.gov/pubmed/28675025
https://www.proquest.com/docview/1915882756
https://pubmed.ncbi.nlm.nih.gov/PMC5912142
http://www.e-crt.org/upload/pdf/crt-2016-446.pdf
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002335623
UnpaywallVersion publishedVersion
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Cancer Research and Treatment, 2018, 50(2), , pp.614-623
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: ABDBF
  dateStart: 20120301
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: DIK
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: 5-W
  dateStart: 20010101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2005-9256
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0064371
  issn: 1598-2998
  databaseCode: RPM
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb5swFD5qE2nby-4Xdqm8aZeHihSIMbC3dG3UTWubTYvUPVlgmxYlM4iLpu3X7xhC2qrb1CcQPgJhf5a_D46_A_DaVbEvoljZSI4DFCgptUPpCFuINHAUcuC4dbw5PGIHc_rpxD_ZgL4IYptVaYuy22zQFMs8ljuFTHfwEg6oy2yULyO8sAlD5iP7HsBwfjSbfG9tUSOzoaAtf9sabEa4nHe57hRZgbmFSeViI2rY7oVVaFOX6d8I5tU8yZuNLuJfP-Pl8sIiNL0DX_qtPF3uyWLU1MlI_L7q7Hjt97sLt1eMlEw6CN2DDaXvw43D1T_3B1CduyFXJNaSHBeZNmAlbSKdkqTOyb6Wdp7an7NUkb2sEo1JrtXvybTMf5Bj3VpjI6Cqd-0dvipTJFTXZNZ_V8GG2fm2z-ohzKf73z4c2KtSDbagIa1tOg58JsZhEDgxVRFVaeBJxlKhqGsUnasElQKjAuUhAlD0IDSER6WrmIiUN34EA51r9QRIYMwkA-F7IkyoI72IKTcJFdIen3qJTCzY7oeOi5WPuSmnseSoZ8xAc-xLbvqSY19a8GYdXXT-Hf-Ie4Uo4AuRcWO4bY6nOV-UHGXFRz5GXuSw0IKXPUg4zkLzayXWKm8qjqrXR62CnWDB4w4068d5IYoypJYWBJfgtA4wD7zcorOz1unbj1xjiWfB2zXw_vsWT68b-Axu4WnYpSA9h0FdNuoFsqs62YLhZHdvd7q1mlh_AJNhJF8
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ZbtQwFL1qpxLwwr6ETQaxPKBMk4xjJ7xV0FFBtB0QI7VPVmI7bTSDE2URgq_nOplMWxVQnxLFV4liH8vnJNfnArzydRLKONEukmOOAiWjbqQ86UqZcU8jB046x5v9A7Y3p5-PwqMNGIogdlmVrqz6zQZtuSwStV2qbBsv4YD6zEX5MsYLm7DFQmTfI9iaH8x2jjtb1NhuKOjK33YGmzEu532uO0VWYG9hU7nYmFq2e24V2jRV9jeCeTlP8npryuTXz2S5PLcITW_B12ErT597shi3TTqWvy87O175_W7DzRUjJTs9hO7AhjZ34dr-6p_7PajP3JBrkhhFDsvcWLCSLpFOK9IUZNcot8jcL3mmyce8lq1NrjXvybQqfpBD01ljI6Dqt90dvmlbJNQ0ZDZ8V8GG2dm2z_o-zKe73z_suatSDa6kEW1cOuEhk5OIcy-hOqY644FiLJOa-lbR-VpSJTGK6wARgKIHoSEDqnzNZKyDyQMYmcLoR0C4NZPkMgxklFJPBTHTfhpppD0hDVKVOvBuGDohVz7mtpzGUqCesQMtsC-F7UuBfenA63V02ft3_CPuJaJALGQurOG2PZ4UYlEJlBWfxAR5kcciB14MIBE4C-2vlcTooq0Fqt4QtQp2ggMPe9CsHxdEKMqQWjrAL8BpHWAfeLHF5Ked03cY-9YSz4E3a-D99y0eXzXwCdzA06hPQXoKo6Zq9TNkV036fDWh_gB46SLt
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Experiences+and+Opinions+Related+to+End-of-Life+Discussion%3A+From+Oncologists%27+and+Resident+Physicians%27+Perspectives&rft.jtitle=Cancer+research+and+treatment&rft.au=Koh%2C+Su-Jin&rft.au=Kim%2C+Shinmi&rft.au=Kim%2C+JinShil&rft.au=Keam%2C+Bhumsuk&rft.date=2018-04-01&rft.issn=2005-9256&rft.eissn=2005-9256&rft.volume=50&rft.issue=2&rft.spage=614&rft_id=info:doi/10.4143%2Fcrt.2016.446&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon